The 1998 Nobel prize in Medicine: clinical implications for 1999 and beyond

Abstract

References

Furchgott RF , Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.

Ignarro LJ , Byrns RE , Buga GM , Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866-879.

Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte P (ed). Mechanisms of Vasodilation. New York: Raven Press, 1988: 401-404.

Palmer RMJ , Ferridge AG , Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.

Murad F. The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. JAMA 1996; 276: 1189-1192.

Palmer RMJ , Ashton DS , Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.

Cooke JP , Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489-509.

Albina JE , Reichner JS. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev 1998; 17: 39-53.

Lancaster JR Jr , Hibbs JB Jr. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A 1990; 87: 1223-1227.

10.

Nelson RJ , Demas GE , Huang PL et al. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 1995; 378: 383-386.

11.

Cooke JP , Stamler J , Andon N , Davies PF , McKinley G , Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 1990; 259 (3 Pt 2): H804-H12.

12.

Stamler JS , Loh E , Roddy MA , Currie KE , Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89: 2035-2040.

13.

Garg UC , Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.

14.

von der Leyen HE , Gibbons GH , Morishita R et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995; 92: 1137-1141.

15.

Schwarzacher SP , Lim TT , Wang BY et al. Local intramural delivery of l-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 1997; 95: 1863-1869.

16.

Lablanche JM , Grollier G , Lusson JR et al. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. Circulation 1997; 95: 83-89.

17.

Babaei S , Teichert-Kuliszewska K , Monge JC , Mohamed F , Bendeck MP , Stewart DJ. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 1998; 82: 1007-1015.

18.

Papapetropoulos A , Garcia-Cardena G , Madri JA , Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100: 3131-3139.

19.

Tsao PS , Lewis NP , Alpert S , Cooke JP. Exposure to shear stress alters endothelial adhesiveness: role of nitric oxide. Circulation 1995; 92: 3513-3519.

20.

Tsao PS , Buitrago R , Chan JR , Cooke JP. Fluid flow inhibits endothelial adhesiveness: nitric oxide and transcriptional regulation of VCAM-1. Circulation 1996; 94: 1682-1689.

21.

Tsao PS , Wang BY , Buitrago R et al. Nitric oxide regulates monocyte chemotactic protein-1. Circulation 1997; 96: 934-940.

22.

Stamler JS , Mendelsohn ME , Amarante P et al. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989; 65: 789-795.

23.

Creager MA , Cooke JP , Mendelsohn ME et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-234.

24.

Zeiher AM , Drexler H , Saurbier B , Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92: 652-662.

25.

Celermajer DS , Sorensen KE , Bull C , Robinson J , Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. JAm Coll Cardiol 1994; 24: 1468-1474.

26.

Cayatte AJ , Palacino JJ , Horten K , Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 753-759.

27.

Vallance P , Leone A , Calver A , Collier J , Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575.

28.

Matsuoka H , Itoh S , Kimoto M et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hyper-tension. Hypertension 1997; 29: 242-247.

29.

Circulation 1998; 98: I733-I733.

30.

Boger RH , Bode-Boger SM , Szuba A et al. ADMA . A novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847.

31.

Miyazaki H , Matsuoka H , Cooke JP et al. Endogenous nitric oxide synthase inhibitor, a novel marker of atherosclerosis circulation. Circulation 1999; 99: 1141-1146.

32.

Faraci FM , Brian JE , Heistad DD. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol 1995; 269: H1522-H27.

33.

Cooke JP , Singer AH , Tsao P et al. Anti-atherogenic effects of l-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-1172.

34.

Aji W , Ravalli S , Szabolcs M et al l-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 1997; 95: 430-437.

35.

Candipan RC , Wang B , Buitrago R et al. Regression or progression: dependency upon vascular nitric oxide. Arterioscler Thromb Vasc Biol 1996; 16: 44-50.

36.

Boger RH , Bode-Boger SM , Brandes RP et al. Dietary l-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation 1997; 96: 1282-1290.

37.

Creager MA , Gallagher SJ , Girerd XJ , Coleman SM , Dzau VJ , Cooke JP. l-arginine improves endothelium-dependent vasodilation in hyper-cholesterolemic humans. J Clin Invest 1992; 90: 1248-1253.

38.

Drexler H , Zeiher AM , Meinzer K , Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by l-arginine. Lancet 1991; 338: 1546-1550.

39.

Lerman A , Burnett JC Jr , Higano ST , McKinley LJ , Holmes DR Jr. Long-term l-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998; 97: 2123-2128.

40.

Ceremuzynski L , Chamiec T , Herbaczynska-Cedro K. Effect of supplemental oral l-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 1997; 80: 331-333.

41.

Boger RH , Bode-Boger SM , Thiele W , Creutzig A , Alexander K , Frolich JC. Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 1998; 32: 1336-1344.

42.

Levine GN , Frei B , Koulouris SN , Gerhard MD , Keaney JF Jr , Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107-1113.

43.

Gerhard M , Walsh BW , Tawakol A et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in post-menopausal women. Circulation 1998; 98: 1158-1163.

44.

Stroes E , Kastelein J , Cosentino F et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997; 99: 41-46.

45.

Treasure CB , Klein JL , Weintraub WS et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487.